Evidence map›Paper›PMID 33614561›Full record

ReviewFrontiers in pediatrics2021

Atypical Presentations of IPEX: Expect the Unexpected.

Filippo Consonni, Sara Ciullini Mannurita, Eleonora Gambineri

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05241444 (Phase 1 Study of Autologous CD4^LVFOXP3 in Participants With Immune Dysregulation Polyendocrinopathy Enteropathy X-linked), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05241444 phase1recruitingnot on this mapstarted 2022, after this paper: background citation

Phase 1 Study of Autologous CD4^LVFOXP3 in Participants With Immune Dysregulation Polyendocrinopathy Enteropathy X-linked (IPEX) Syndrome

TypeinterventionalSponsorBacchetta, Rosa, MDRan2022 to 2037Enrolled30ConditionsIPEXArmsCD4^LVFOXP3
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A novel FOXP3 gene variant causing neonatal diabetes and fatal enteropathy.Annals of pediatric endocrinology & metabolism · 2026
    Article
  9. Inborn errors of regulatory T-cell differentiation and function.The Journal of allergy and clinical immunology · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Monogenic inflammatory bowel disease: An unfolding enigma.World journal of clinical pediatrics · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Dysfunction of Foxp3International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Filippo ConsonniAnna Meyer Children's Hospital, University of Florence, Florence, Italy.
Sara Ciullini MannuritaDivision of Pediatric Oncology/Hematology, Meyer University Children's Hospital, Florence, Italy.
Eleonora GambineriDivision of Pediatric Oncology/Hematology, Meyer University Children's Hospital, Florence, Italy.
University of Florence · ITMeyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune dysregulation, polyendocrinopathy, and enteropathy, X-linked (IPEX) syndrome is a rare disorder that has become a model of monogenic autoimmunity. IPEX is caused by mutations in

Indexed as

FOXP3immune dysregulationIPEXprimary immunodeficienciesregulatory T cells

Identifiers

PMID33614561
PMCPMC7892580
OpenAlexW3127379772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.